Sort
8,912 grants matching “sars cov 2”
Targeting Grainyhead-Like 2 Suppresses Entry Factors of SARS-CoV-2 in Epithelial Cells of Oral Mucosa.
$195,000Wei Chen · University Of California Los Angeles · R21 · FY2023 · DE
Probing the particle size-viability relationship in bioaerosols through size-controlled measurements
$195,000Hui Ouyang · University Of Texas Dallas · R21 · FY2024 · AI
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$195,000Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
A Mixed Methods Study of Chronic Kidney Disease (CKD) Self-Management
$194,851Sarah Jeanne Schrauben · University Of Pennsylvania · K23 · FY2021 · DK
Biological Sequence Quality Control and Organization
$194,681Eric Nawrocki · National Library Of Medicine · ZIB · FY2022 · LM
SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use
$194,620Jacek Skarbinski · Kaiser Foundation Research Institute · U01 · FY2022 · CA
Chitin and chitinases in SARS-CoV-2 infection
$194,584Steven Van Dyken · Washington University · R21 · FY2023 · AI
Targeting SARS-CoV-2 RNA Pseudoknots Using Triplex-Forming Peptide Nucleic Acids
$194,540Eriks Rozners · State University Of Ny,Binghamton · R21 · FY2022 · AI
SARS-CoV-2 pathogenesis and countermeasures
$194,529Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Leveraging Pathogen-Host Networks to Identify Virus-specific and Estradiol-regulated Mechanisms during Respiratory Infection
$194,425Jason Edward Shoemaker · University Of Pittsburgh At Pittsburgh · R21 · FY2024 · AI
Defining vaccine immunogenicity and adoptive transfer in hematopoietic stem cell transplant recipients
$194,400Amy Caryn Sherman · Brigham And Women'S Hospital · K23 · FY2025 · AI
Mentoring investigators to improve health outcomes among persons with opioid and tobacco use disorder
$194,400Shadi Nahvi · Albert Einstein College Of Medicine · K24 · FY2022 · DA
Mentoring investigators to improve health outcomes among persons with opioid and tobacco use disorder
$194,400Shadi Nahvi · Albert Einstein College Of Medicine · K24 · FY2023 · DA
Mentoring investigators to improve health outcomes among persons with opioid and tobacco use disorder
$194,400Shadi Nahvi · Albert Einstein College Of Medicine · K24 · FY2024 · DA
Mentoring investigators to improve health outcomes among persons with opioid and tobacco use disorder
$194,400Shadi Nahvi · Albert Einstein College Of Medicine · K24 · FY2025 · DA
COVID-19 comorbidity studies in Syrian hamster models
$194,375Yoshihiro Kawaoka · University Of Wisconsin-Madison · R21 · FY2021 · AI
Identifying placental tissue tropism and cellular mechanisms of Ebola Virus transmission from mother to fetus in pregnancy
$194,375Wendy Jean Maury · University Of Iowa · UH2 · FY2025 · AI
Structural investigations of coronavirus spike protein
$194,375Syed Saif Hasan · University Of Maryland Baltimore · R21 · FY2025 · AI
A Novel Cell-based System for the Search of SARS-CoV-2 ORF3a Inhibitors against COVID-19
$194,375Richard Yuqi Zhao · University Of Maryland Baltimore · R21 · FY2025 · AI
Vaccine-Induced Mucosal T-Cell Immunity to Respiratory Viruses in Dirty Mice
$194,375Marulasiddappa Suresh · University Of Wisconsin-Madison · R21 · FY2024 · AI
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
$194,375Ross M Kedl · University Of Colorado Denver · R21 · FY2023 · AI
SARS-CoV-2 N interactions with RNA and host cell cyclophilin-A
$194,375Elan Z Eisenmesser · University Of Colorado Denver · R21 · FY2022 · AI
Modeling the contribution of coronavirus cellular tropism to viral pathogenesis
$194,375Beverly H Koller · Univ Of North Carolina Chapel Hill · R21 · FY2024 · AI
Trimerization of the N-terminal Domain of ACE2 for Bifunctional Trapping of Future SARS-CoV-2 Variants
$194,375Rihe Liu · Univ Of North Carolina Chapel Hill · R21 · FY2022 · AI
Complex Odor Recognition of the Main Olfactory Bulb
$194,375Diego Restrepo · University Of Colorado Denver · R01 · FY2020 · DC